Clinical Trials Sponsored by Tessa Therapeutics

Total 6448 results

Hasselt University
Jessa Hospital

Completed

Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity (GIIADMT1)

Diabetes Mellitus, Type 1

Belgium
Hasselt University
Jessa Hospital

Completed

Oral β-Alanine Supplementation in Patients With COPD (BACOPD)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium
Jessa Hospital
Hasselt University

Completed

Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft (NOMICS)

Delirium | Postoperative Cognitive Dysfunction | Cerebrovascular Accident

Belgium
Hasselt University
Jessa Hospital

Completed

Reliable Hypertension Diagnosis Based on 24 ABPM

Arterial Hypertension

Belgium
Hasselt University
Jessa Hospital

Completed

Intra- And Inter-operator Reliability Of Isometric Back And Abdominal Muscle Strength Testing In Healthy Controls And Persons With Nonspecific Chronic Low Back Pain. (LBP-BIO-REL)

Chronic Low Back Pain

Belgium
Hasselt University
Jessa Hospital

Completed

Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.

Diabetes Mellitus, Type 1

Belgium
Hasselt University
Jessa Hospital

Completed

Influence of Training Intensity in Coronary Artery Disease

Coronary Artery Disease

Belgium
Hasselt University
Jessa Hospital

Completed

Left Atrial Function in Recurrent Stroke of Unknown Cause

Stroke

Belgium
Hasselt University
Jessa Hospital

Unknown

Education-based Physical Therapy Approach for Adhesive Capsulitis

Adhesive Capsulitis

Belgium
Hasselt University
Jessa Hospital

Completed

Technology-supported Exercise Therapy for Patients With Chronic Low Back Pain

Chronic Non-specific Low Back Pain

Belgium
Hasselt University
Jessa Hospital

Completed

Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents (T1DM)

Type1diabetes

Belgium
Hasselt University
Jessa Hospital; VITO

Unknown

Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers (NiNbI)

Wheezing | Noisy Breathing Infants | Noist Breathing Toddlers | Rattling

Belgium
pico-tesla Magnetic Therapies, LLC

Completed

Study of Magnetic Fields for Treatment of Parkinson's Disease

Parkinson's Disease

United States
pico-tesla Magnetic Therapies, LLC

Terminated

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Type 2 Diabetes

United States
Ranok Therapeutics (Hangzhou) Co., Ltd.

Recruiting

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Advanced Solid Tumor | DLBCL

United States
Ziekenhuis Oost-Limburg
Jessa Hospital

Recruiting

Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation (PRAISE-MR)

Heart Failure With Preserved Ejection Fraction | Functional Mitral Regurgitation

Belgium
pico-tesla Magnetic Therapies, LLC

Unknown

Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

Quality of Life | Parkinson's Disease

United States
pico-tesla Magnetic Therapies, LLC

Unknown

Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease

Alzheimer's Dementia

United States
pico-tesla Magnetic Therapies, LLC

Completed

Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

Parkinson's Disease
pico-tesla Magnetic Therapies, LLC

Completed

Evaluation of Magnetic Fields to Treat Fibromyalgia

Fibromyalgia
pico-tesla Magnetic Therapies, LLC

Withdrawn

Study of Magnetic Fields to Treat Alzheimer's Disease

Alzheimer's Disease

United States
pico-tesla Magnetic Therapies, LLC

Completed

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Type II Diabetes Mellitus

United States
University Hospital, Antwerp
Jessa Hospital

Completed

Survey on the Future of Telemedicine in the Daily Care of Cardiology Patients. (MEDICAR)

Cardiovascular Diseases

Belgium
PXL University College
Jessa Hospital

Unknown

Effectiveness Study "HospiAvontuur":

Children | Surgery | Preoperative Anxiety

Belgium
pico-tesla Magnetic Therapies, LLC

Withdrawn

Low Level Magnetic Fields for the Treatment of Osteoarthritis of the Hip

Osteoarthritis of the Hip

United States
TESS Research Foundation
Stanford University

Enrolling by invitation

SLC13A5 Deficiency Natural History Study - Remote Only

Epilepsy | Movement Disorders | Rare Diseases | Genetic Disorder | Citrate Transporter Deficiency | SLC13A5 Deficiency | EIEE25 | Kohlschutter-Tonz Syndrome (Non-ROGDI) | 17p13.1 Deletions Confined to SLC13A5 Gene | Citrate Transporter Disorder

United States
Maastricht University Medical Center
Jessa Hospital

Not yet recruiting

The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients (DIRECT)

Cancer of Prostate
Frank Vandenabeele
Jessa Hospital

Recruiting

Skeletal Muscle Wasting in ICU Patients (IC-MPS)

Critical Illness | Muscle Atrophy

Belgium
PXL University College
Jessa Hospital; ZOL

Active, not recruiting

The Newborn Early Warning System (NEWS)

Development Tool NEWS

Belgium
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)

Heart Failure With Preserved Ejection Fraction

United States, Canada
Maastricht University Medical Center
Jessa Hospital

Enrolling by invitation

Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI (BREACH-ECGI)

Ventricular Fibrillation | Heart Arrest | Ventricular Tachycardia | Cardiac Arrest | Congenital Heart Disease | Ventricular Arrythmia | Polymorphic Ventricular Tachycardia | Sudden Cardiac Death | Cardiac Arrhythmia | Cardiac Death | Sudden Cardiac Death Due to Cardiac Arrhythmia | Sudden Cardiac Arrest

Netherlands
KU Leuven
Hasselt University; Jessa Hospital

Completed

Telerehabilitation in Coronary Heart Disease (TRiCH)

Myocardial Infarction | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic Guidance

Belgium
Hasselt University
Jessa Hospital; Maastricht University

Completed

The Role of Atrial Natriuretic Peptide in the Lipolytic Process: Effect of Obesity and Exercise (BALO)

Obesity

Belgium
Vrije Universiteit Brussel
Jessa Hospital; Roche Diagnostics

Recruiting

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment (DECONGEST)

Acute Heart Failure | Diuretics Drug Reactions

Belgium
Jessa Hospital
Hasselt University; University Hospital, Antwerp

Active, not recruiting

Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients (MIA-COVID-19)

COVID-19

Belgium
Cristiana Sessa

Completed

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor (IOSI-NDU-001)

Breast Cancer | NSCLC | Endometrial Cancer | Ovary Cancer | Small Cell Lung Cancer (SCLC) | Head and Neck (HNSCC)

Switzerland
Hasselt University
Jessa Hospital; Ziekenhuis Oost-Limburg

Completed

A Two-way Communication System to Coach Elderly Patients With Heart Failure (CardioCoach)

Heart Failure

Belgium
Hamid Al-Essa Organ Transplant Center

Completed

Acute Kidney Injury Among COVID-19 Positive Patients (AKI-COVID-19)

COVID-19 Positive Patients With Acute Kidney Injury

Kuwait
Hamid Al-Essa Organ Transplant Center

Completed

PCSK 9 Inhibition as Secondary Prevention in Renal Transplant Patients

Kideny Transplant Recipients With High Cardiovascular Risk Score

Kuwait
Eikon Therapeutics
Impact Therapeutics, Inc.

Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Advanced Solid Tumor

Australia, United States
APRINOIA Therapeutics, LLC

Active, not recruiting

A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

Alzheimer Disease | Tauopathies | Healthy Volunteers

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Renal Cell Carcinoma

United States, Australia, Canada, Netherlands
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Clear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal Carcinoma

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)

T Cell Lymphoma

United States, Australia, Canada
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)

B-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALL

United States, Spain, Canada, France, Germany, Australia
Bacainn Therapeutics, Inc.

Completed

A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

Healthy Volunteers

United States
Celsus Therapeutics PLC

Terminated

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (C012013)

Atopic Dermatitis

Israel
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Follicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

United States
CRISPR Therapeutics AG

Enrolling by invitation

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Hematologic Malignancy | Solid Malignancy

United States

Clinical Trials Sponsored by Tessa Therapeutics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations